Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week ...

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...

Ozempic and other drugs like it have been threatening the more traditional weight loss industry since they premiered — and it ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...

Semaglutide effectively treats liver disease in two thirds ... United States, and funded by Novo Nordisk. Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as ...

Compounded versions of Novo Nordisk’s Wegovy and Ozempic will ... When the FDA declared the shortage resolved for semaglutide, the main pharmaceutical ingredient in Wegovy and Ozempic, the ...

Novo Nordisk’s diabetes blockbuster-in-waiting semaglutide is edging closer to approval, after advisers to the US regulator unanimously voted in favour of approval. The 16 experts from the FDA ...

A federal judge April 24 rejected a bid by compounding pharmacies to continue selling less expensive copies of semaglutide, Novo Nordisk's blockbuster drug sold under the brands Wegovy and Ozempic.